After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ACRV belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Acrivon Therapeutics Inc is $75.42M. A total of 88822.0 shares were traded on the day, compared to an average of 717.15K shares.
In the most recent transaction, PERCEPTIVE ADVISORS LLC sold 437,881 shares of ACRV for 1.41 per share on Apr 30 ’25. After the transaction, the 10% Owner now owns 3,403,025 company shares. In a previous transaction on May 01 ’25, PERCEPTIVE ADVISORS LLC sold 298,886 shares at 1.34 per share. ACRV shares that 10% Owner owns now total 3,104,139.
Among the insiders who sold shares, PERCEPTIVE ADVISORS LLC disposed of 1,054,669 shares on Apr 25 ’25 at a per-share price of $1.95. This resulted in the 10% Owner holding 4,306,189 shares of ACRV after the transaction. In another insider transaction, PERCEPTIVE ADVISORS LLC sold 250,000 shares at $1.41 per share on Apr 29 ’25. Company shares held by the 10% Owner now total 3,840,906.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ACRV has a high of $8.00 and a low of $1.05.
As of this writing, ACRV has an earnings estimate of -$0.47 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.52. The company reported an EPS of -$0.54 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ACRV’s latest balance sheet shows that the firm has $99.60M in Cash & Short Term Investments as of fiscal 2021. There were $5.63M in debt and $2.91M in liabilities at the time. Its Book Value Per Share was $4.08, while its Total Shareholder’s Equity was -$23.81M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ACRV is Buy with a score of 4.60.
